12 Health Care Stocks Moving In Thursday's Intraday Session

Gainers

  • Precigen PGEN stock rose 25.0% to $1.55 during Thursday's regular session. As of 13:30 EST, Precigen's stock is trading at a volume of 6.1 million, which is 491.0% of its average full-day volume over the last 100 days. The company's market cap stands at $395.9 million. The company's, Q2 earnings came out yesterday.
  • Science 37 Hldgs SNCE shares increased by 24.95% to $0.52. As of 13:30 EST, this security is trading at a volume of 27.0 million shares, making up 3026.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $60.5 million. As per the press release, Q2 earnings came out 2 days ago.
  • Repare Therapeutics RPTX shares moved upwards by 22.68% to $10.33. Trading volume for Repare Therapeutics's stock is 107.0K as of 13:30 EST. This is 109.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $434.7 million. As per the news, the Q2 earnings report came out yesterday.
  • Macrogenics MGNX stock increased by 21.08% to $6.03. Trading volume for Macrogenics's stock is 4.2 million as of 13:30 EST. This is 844.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $372.8 million. The company's, Q2 earnings came out yesterday.
  • Atara Biotherapeutics ATRA shares rose 21.01% to $2.27. As of 13:30 EST, Atara Biotherapeutics's stock is trading at a volume of 1.1 million, which is 58.2% of its average full-day volume over the last 100 days. The company's market cap stands at $230.0 million. As per the news, the Q2 earnings report came out 2 days ago.
  • LifeMD LFMD stock rose 19.18% to $4.36. Trading volume for LifeMD's stock is 707.4K as of 13:30 EST. This is 193.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $146.1 million. As per the press release, Q2 earnings came out yesterday.

Losers

  • Galera Therapeutics GRTX stock fell 83.9% to $0.36 during Thursday's regular session. Trading volume for Galera Therapeutics's stock is 34.5 million as of 13:30 EST. This is 3149.2% of its average full-day volume over the last 100 days. The company's market cap stands at $15.4 million.
  • Matinas BioPharma Hldgs MTNB stock declined by 48.49% to $0.17. As of 13:30 EST, this security is trading at a volume of 8.2 million shares, making up 1702.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $37.4 million. As per the press release, Q2 earnings came out yesterday.
  • Surrozen SRZN stock declined by 35.79% to $0.57. Trading volume for this security as of 13:30 EST is 855.9K, which is 951.3% of its average full-day volume over the last 100 days. The company's market cap stands at $17.1 million. As per the news, the Q2 earnings report came out yesterday.
  • X4 Pharmaceuticals XFOR stock fell 33.24% to $1.09. The current volume of 13.0 million shares is 376.3% of X4 Pharmaceuticals's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $173.7 million. As per the press release, Q2 earnings came out today.
  • Virios Therapeutics VIRI shares fell 33.12% to $1.05. Trading volume for Virios Therapeutics's stock is 3.3 million as of 13:30 EST. This is 437.7% of its average full-day volume over the last 100 days. The company's market cap stands at $19.5 million. As per the press release, Q2 earnings came out today.
  • Strata Skin Sciences SSKN stock fell 23.87% to $0.67. The current volume of 296.1K shares is 3737.1% of Strata Skin Sciences's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $23.3 million. As per the news, the Q2 earnings report came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!